News

Ozempic vs. Zepbound: Which Is Better For Weight Loss?
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
New Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Medical Dialogues4d
Tirzepatide Demonstrates Consistent Efficacy in OSA Across All Severity Levels, suggests research
A recent post-hoc analysis of the SURMOUNT-OSA trials revealed that tirzepatide significantly improves obstructive sleep ...
Mounjaro: Everything You Need To Know About This Medication
Mounjaro is the brand name for tirzepatide, a prescription medication developed by Eli Lilly that is primarily used to treat ...
Neurology Advisor4d
How GLP-1s Could Help People Sleep Better — Beyond Weight Loss
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The NEXT generation ‘fat jabs’ are already here: They’re cheaper, easier to take & you could keep the weight off longer
EVERYONE’S talking about fat jabs – the ‘miracle’ injections trimming inches off waistlines, and helping turn the tide on the ...
Arrowhead Pharmaceuticals, Inc. (ARWR)’s ARO-ALK7 Enters Phase 1/2a Study
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...
AFP6d
Latest Data from SURPASS-3 Trial Gleans Insight Into the Association of Tirzepatide Treatment with Changes in Muscle Composition in Type 2 Diabetes
The analysis explored data from the trial to determine ... data from over 200 participants analyzed using AMRA ® Researcher, indicate that decreases in muscle volume with tirzepatide largely ...
Pulse Today6d
GPs need to engage with obesity management as weight-loss jabs are rolled out, say researchers
Weight-loss drugs cannot be a short-term solution and GPs will need to engage with obesity management as the medicines are ...
Global supply strains and patent clock push Novo Nordisk into tight corner in India’s obesity drug race
As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...
Umbrella Labs Expands Research Portfolio with Availability of Retatrutide (LY3437943), a Next-Generation Triple Agonist Peptide
TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs , a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...